Zosuquidar trihydrochlorideProduct ingredient for Zosuquidar
- Name
- Zosuquidar trihydrochloride
- Drug Entry
- Zosuquidar
Zosuquidar is a compound of antineoplastic drug candidates currently under development. It is now in "Phase 3" of clinical tests in the United States. Its action mechanism consists of the inhibition of P-glycoproteins; other drugs with this mechanism include tariquidar and laniquidar.
- Accession Number
- DBSALT000558
- Structure
Structure for Zosuquidar trihydrochloride (DBSALT000558)
- Synonyms
- Zosuquidar triHCl